Which Statin Has the Least Side Effects?

Which statin is least likely to cause muscle pain or cramps?

No individual statin has been shown clearly to cause fewer muscle symptoms than all the others. The Cholesterol Treatment Trialists’ Collaboration’s 2022 analysis of 19 double-blind statin-versus-placebo trials found no clear evidence that muscle-symptom risk differed among individual statins.

In that analysis, muscle pain or weakness was reported by 27.1% of statin recipients and 26.6% of placebo recipients. During the first year, the absolute excess was 11 events per 1,000 person-years; the authors estimated that more than 90% of muscle-symptom reports in the statin group were not caused by the statin. These findings do not mean symptoms should be dismissed. They mean timing alone cannot prove their cause.

When symptoms are linked to a statin, the pattern and context matter. NHS England describes typical statin-related muscle symptoms as symmetrical pain or weakness in large muscle groups near the body’s center, often worse with exercise. The pathway also recommends looking for other causes rather than assuming the medicine is responsible.

Is pravastatin better tolerated than rosuvastatin?

Pravastatin is not proven to be better tolerated than rosuvastatin for everyone. Trial evidence does not establish a clear muscle-symptom advantage for one statin, though pravastatin may suit some people when CYP450-mediated drug interactions are a concern.

The National Lipid Association notes that pravastatin and pitavastatin do not undergo significant CYP450 metabolism. That can make them reasonable options when a person’s other medicines raise concern about this pathway, but it does not make them interaction-free or guarantee fewer symptoms. Other interactions and personal risk factors still matter.

Rosuvastatin has its own considerations. The FDA’s 2026 CRESTOR prescribing information identifies higher doses, age 65 or older, uncontrolled hypothyroidism, renal impairment, and certain concomitant medicines as myopathy risk factors. The label says myopathy risk is greater with rosuvastatin 40 mg daily than with lower doses. These are prescribing considerations, not proof that rosuvastatin is less tolerable than pravastatin for a given person.

Do statin side effects depend more on the drug or the dose?

Both can matter, but dose and a person’s health and medicine profile can shift risk even when no statin consistently ranks as the easiest to tolerate. The 2022 trial analysis found somewhat higher relative risk of muscle symptoms with more intensive regimens than with moderate- or lower-intensity regimens, while finding no clear evidence of differences among individual statins.

The National Lipid Association’s 2022 clinical perspective estimates that muscle symptoms occurring in time with statin use affect about 10% of people, while pharmacological muscle symptoms caused by the statin are estimated at 1%–2%. The distinction matters: a symptom that begins while taking a medicine deserves review, but does not by itself establish a drug reaction.

Risk assessment also includes factors beyond dose. The FDA rosuvastatin label identifies age, uncontrolled hypothyroidism, renal impairment, certain other medicines, and higher doses. NHS England additionally lists older age, frailty, kidney or liver impairment, hypothyroidism, and drug interactions as factors to review.

When symptoms arise, clinician-guided options can include reassessing possible causes, reducing the dose, switching to a different statin, or trying less frequent dosing when appropriate. The National Lipid Association defines statin intolerance using a history of symptoms that improve after dose reduction or stopping, and exposure to at least two statins, including one at the lowest approved daily dose. That definition helps distinguish a sustained intolerance from a single difficult trial.

Which statin has the fewest interactions with other medications?

Pravastatin and pitavastatin have fewer concerns related to CYP450 metabolism, but no statin can be assumed to have no interactions. The National Lipid Association identifies both as options that may be reasonable when CYP450-mediated interactions are a concern, while noting they can still have other interactions.

The NHS lists some antibiotics, antifungals, HIV medicines, ciclosporin, and colchicine among medicines that can increase side-effect risk or otherwise interact with statins. The exact combination matters, so a medication review should include prescriptions, non-prescription medicines, herbal remedies, and foods that could interact.

A useful discussion with a prescriber or pharmacist includes when symptoms began, which muscles are affected, whether symptoms are symmetrical or worsen with exercise, and whether any medicines or health conditions changed around the same time. The FDA advises promptly reporting unexplained muscle pain, tenderness, or weakness, particularly with malaise or fever. Severe symptoms or weakness need prompt assessment; NHS England says suspected rhabdomyolysis requires urgent inpatient assessment.

Do not change treatment based only on a comparison chart. The NHS advises discussing suspected side effects with a doctor, who can assess causes and consider changing the dose or prescribing another statin.